IMC-I109V

N/A

Report date: 2025/04/11 11:34:21

Base Information

Drug NameIMC-I109V

Drug Alias NameIMC-I109V

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionHBsAg modulators

TargetsHepatitis B Surface Antigens

Therapy Area/IndicationsHepatitis B, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited StatesUkraine +[13]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesImmunocore Ltd

China Registration ClassN/A

Develop Information

Active CompaniesImmunocore Ltd

Inactive CompaniesN/A

Active IndicationsHepatitis B, Chronic

Inactive IndicationsN/A

Other Information

ATC CodeN/A